Western Pacific Wealth Management LP Has $102,000 Holdings in CME Group Inc. (NASDAQ:CME)

Western Pacific Wealth Management LP grew its holdings in shares of CME Group Inc. (NASDAQ:CME) by 116.8% during the third quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 464 shares of the financial services provider’s stock after buying an additional 250 shares during the period. Western Pacific Wealth Management LP’s holdings in CME Group were worth $102,000 as of its most recent filing with the SEC.

Other large investors also recently modified their holdings of the company. Y.D. More Investments Ltd bought a new position in CME Group during the second quarter worth $36,000. McClarren Financial Advisors Inc. raised its position in shares of CME Group by 66.1% during the second quarter. McClarren Financial Advisors Inc. now owns 196 shares of the financial services provider’s stock worth $39,000 after purchasing an additional 78 shares during the period. Asset Dedication LLC lifted its holdings in shares of CME Group by 515.2% in the 2nd quarter. Asset Dedication LLC now owns 203 shares of the financial services provider’s stock worth $40,000 after purchasing an additional 170 shares in the last quarter. Thurston Springer Miller Herd & Titak Inc. grew its position in CME Group by 62.2% in the 3rd quarter. Thurston Springer Miller Herd & Titak Inc. now owns 193 shares of the financial services provider’s stock valued at $43,000 after purchasing an additional 74 shares during the period. Finally, Bank & Trust Co bought a new stake in CME Group during the 2nd quarter valued at $76,000. Institutional investors and hedge funds own 87.75% of the company’s stock.

Insider Activity

In related news, Director Bryan T. Durkin sold 7,593 shares of the business’s stock in a transaction that occurred on Friday, August 30th. The shares were sold at an average price of $214.59, for a total transaction of $1,629,381.87. Following the completion of the transaction, the director now owns 55,607 shares of the company’s stock, valued at approximately $11,932,706.13. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. In related news, Director Bryan T. Durkin sold 7,593 shares of the stock in a transaction on Friday, August 30th. The stock was sold at an average price of $214.59, for a total value of $1,629,381.87. Following the sale, the director now owns 55,607 shares in the company, valued at approximately $11,932,706.13. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Director Martin J. Gepsman sold 400 shares of the business’s stock in a transaction dated Monday, November 4th. The stock was sold at an average price of $222.92, for a total value of $89,168.00. Following the transaction, the director now owns 25,067 shares of the company’s stock, valued at approximately $5,587,935.64. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 15,621 shares of company stock worth $3,441,063 over the last ninety days. Company insiders own 0.30% of the company’s stock.

Analysts Set New Price Targets

CME has been the topic of a number of recent research reports. Oppenheimer raised their price objective on shares of CME Group from $245.00 to $258.00 and gave the company an “outperform” rating in a research note on Thursday, October 24th. Bank of America raised their price target on shares of CME Group from $177.00 to $180.00 and gave the company an “underperform” rating in a research report on Thursday, October 3rd. The Goldman Sachs Group increased their price objective on shares of CME Group from $195.00 to $198.00 and gave the company a “sell” rating in a research note on Thursday, October 3rd. Barclays boosted their target price on CME Group from $219.00 to $231.00 and gave the stock an “equal weight” rating in a research note on Thursday, October 24th. Finally, Royal Bank of Canada reaffirmed a “sector perform” rating and set a $235.00 price target on shares of CME Group in a research report on Thursday, October 24th. Four research analysts have rated the stock with a sell rating, seven have assigned a hold rating and four have issued a buy rating to the stock. Based on data from MarketBeat, CME Group has a consensus rating of “Hold” and an average price target of $222.73.

CME Group Stock Up 0.4 %

CME stock opened at $222.04 on Friday. The stock has a fifty day moving average of $221.36 and a 200-day moving average of $209.75. CME Group Inc. has a fifty-two week low of $190.70 and a fifty-two week high of $230.36. The company has a market capitalization of $79.96 billion, a price-to-earnings ratio of 23.35, a PEG ratio of 5.61 and a beta of 0.55. The company has a debt-to-equity ratio of 0.09, a quick ratio of 1.02 and a current ratio of 1.02.

CME Group (NASDAQ:CME) last issued its earnings results on Wednesday, October 23rd. The financial services provider reported $2.68 earnings per share for the quarter, topping analysts’ consensus estimates of $2.65 by $0.03. The firm had revenue of $1.58 billion during the quarter, compared to analyst estimates of $1.59 billion. CME Group had a net margin of 57.34% and a return on equity of 13.39%. The company’s quarterly revenue was up 18.4% on a year-over-year basis. During the same quarter last year, the business earned $2.25 earnings per share. As a group, equities research analysts predict that CME Group Inc. will post 10.23 earnings per share for the current year.

CME Group Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, December 27th. Stockholders of record on Monday, December 9th will be given a dividend of $1.15 per share. This represents a $4.60 annualized dividend and a dividend yield of 2.07%. CME Group’s dividend payout ratio is presently 48.37%.

About CME Group

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.